Akida Adiham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akida Adiham has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Zhongrui Zhang
College of Pharmacy and Food, Southwest Minzu University, Chengdu, 610041, China
2 shared publications Cairong Han
College of Pharmacy and Food, Southwest Minzu University, Chengdu, 610041, China
1 shared publication- Dapeng Li
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China
1 shared publication - Feifei Huang
College of Pharmacy and Food, Southwest Minzu University, Chengdu, 610041, China
1 shared publication - Hong Li
College of Pharmacy and Food, Southwest Minzu University, Chengdu 610093, China
1 shared publication - Jian Gu
College of Pharmacy, Southwest Minzu University, No. 16, South 4th Section, First Ring Road, Chengdu 610041, China
1 shared publication
Latest Publications
- 24 May 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 350, 120031
Santali Albi Lignum: From traditional efficacies to pharmacological properties and modern therapeutic applications
- 24 May 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 350, 120031
Santali Albi Lignum: From traditional efficacies to pharmacological properties and modern therapeutic applications
- Open Access
- 15 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 696
In Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration
Hepatic fibrosis (HF) is an important pathological state in the progression of chronic liver disease to end-stage liver disease and is usually triggered by alcohol, nonalcoholic fatty liver, chronic hepatitis viruses, autoimmune hepatitis (AIH), or cholestatic liver disease. Research on novel therapies has become a hot topic due to the reversibility of HF. Research into the molecular mechanisms of the pathology of HF and potential drug screening relies on reliable and rational biological models, mainly including animals and cells. Hence, a number of modeling approaches have been attempted based on human dietary, pathological, and physiological factors in the development of HF. In this review, classical and novel methods of modeling HF in the last 10 years were collected from electronic databases, including Web of Science, PubMed, ScienceDirect, ResearchGate, Baidu Scholar, and CNKI. Animal models of HF are usually induced by chemical toxicants, special diets, pathogenic microorganisms, surgical operations, and gene editing. The advantages and limitations of hepatic stellate cells (HSCs), organoids, and 3D coculture-based HF modeling methods established in vitro were also proposed and summarized. This information provides a scientific basis for the discovery of the pathological mechanism and treatment of HF.
- 15 January 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (2) , 696
Open AccessIn Vivo and In Vitro Models of Hepatic Fibrosis for Pharmacodynamic Evaluation and Pathology Exploration
Hepatic fibrosis (HF) is an important pathological state in the progression of chronic liver disease to end-stage liver disease and is usually triggered by alcohol, nonalcoholic fatty liver, chronic hepatitis viruses, autoimmune hepatitis (AIH), or cholestatic liver disease. Research on novel therapies has become a hot topic due to the reversibility of HF. Research into the molecular mechanisms of the pathology of HF and potential drug screening relies on reliable and rational biological models, mainly including animals and cells. Hence, a number of modeling approaches have been attempted based on human dietary, pathological, and physiological factors in the development of HF. In this review, classical and novel methods of modeling HF in the last 10 years were collected from electronic databases, including Web of Science, PubMed, ScienceDirect, ResearchGate, Baidu Scholar, and CNKI. Animal models of HF are usually induced by chemical toxicants, special diets, pathogenic microorganisms, surgical operations, and gene editing. The advantages and limitations of hepatic stellate cells (HSCs), organoids, and 3D coculture-based HF modeling methods established in vitro were also proposed and summarized. This information provides a scientific basis for the discovery of the pathological mechanism and treatment of HF.